Anixa Biosciences, Inc. (ANIX)
2.99
+0.21
(+7.55%)
USD |
NASDAQ |
Oct 23, 16:00
2.97
-0.02
(-0.67%)
After-Hours: 20:00
Anixa Biosciences Market Cap : 103.41M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 103.41M |
| October 22, 2026 | 96.14M |
| October 21, 2026 | 93.72M |
| October 20, 2026 | 92.69M |
| October 19, 2026 | 90.27M |
| October 16, 2026 | 92.34M |
| October 15, 2026 | 96.14M |
| October 14, 2026 | 91.82M |
| October 13, 2026 | 92.34M |
| October 12, 2026 | 98.22M |
| October 09, 2026 | 100.30M |
| October 08, 2026 | 100.64M |
| October 07, 2026 | 102.02M |
| October 06, 2026 | 104.45M |
| October 05, 2026 | 102.02M |
| October 02, 2026 | 102.02M |
| October 01, 2026 | 95.80M |
| September 30, 2026 | 101.33M |
| September 29, 2026 | 98.57M |
| September 28, 2026 | 96.49M |
| September 25, 2026 | 96.14M |
| September 24, 2026 | 96.14M |
| September 23, 2026 | 95.11M |
| September 22, 2026 | 96.49M |
| September 21, 2026 | 93.38M |
| Date | Value |
|---|---|
| September 18, 2026 | 95.80M |
| September 17, 2026 | 95.45M |
| September 16, 2026 | 89.92M |
| September 15, 2026 | 93.03M |
| September 14, 2026 | 96.84M |
| September 11, 2026 | 95.45M |
| September 10, 2026 | 95.11M |
| September 09, 2026 | 97.87M |
| September 08, 2026 | 100.30M |
| September 04, 2026 | 106.17M |
| September 03, 2026 | 103.46M |
| September 02, 2026 | 106.18M |
| September 01, 2026 | 111.27M |
| August 31, 2026 | 113.64M |
| August 28, 2026 | 118.05M |
| August 27, 2026 | 122.12M |
| August 26, 2026 | 122.29M |
| August 25, 2026 | 124.16M |
| August 24, 2026 | 122.80M |
| August 21, 2026 | 125.85M |
| August 20, 2026 | 121.78M |
| August 19, 2026 | 125.85M |
| August 18, 2026 | 116.36M |
| August 17, 2026 | 118.39M |
| August 14, 2026 | 107.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Vicapsys Life Sciences, Inc. | 12.95M |
Market Cap Related Metrics
| Price to Book Value | 7.146 |
| Price | 2.99 |
| Earnings Yield | -10.36% |